Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
Clinical trial NCT02477839 · COMPLETED
Trial details
- NCT number
- NCT02477839
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-05
- Primary completion
- 2020-05-28
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.